Search clinical trials for: darexaban
Total 18 results
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Pharmacodynamics | Japanese | CaucasianGermany
-
Astellas Pharma IncCompletedHealthy Elderly Subject | Pharmacokinetic of YM150Japan
-
Astellas Pharma Europe B.V.CompletedA Study to Find Out How YM150 is Absorbed Into and Eliminated From the Body in Healthy Male SubjectsHealthy Male Subjects | PharmacokineticsNetherlands
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetic of DigoxinFrance
-
Astellas Pharma IncCompletedVenous ThromboembolismJapan
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacodynamic InteractionFrance
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics of Darexaban and MetabolitesFrance
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of YM150Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of YM150Japan
-
Astellas Pharma Europe B.V.CompletedAcute Coronary SyndromePoland, Colombia, Germany, Korea, Republic of, South Africa, Czech Republic, Netherlands, Hungary, Russian Federation, Mexico, Romania, Argentina, Ukraine, Denmark, Slovakia, Belgium, India, Brazil, Australia, Canada, France
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of YM150Japan
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacodynamic InteractionFrance
-
Astellas Pharma IncCompletedVenous ThromboembolismJapan
-
Astellas Pharma IncCompletedVenous ThromboembolismJapan
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedThromboembolismItaly, Spain, Sweden, Austria, Denmark, Russian Federation, Poland, Bosnia and Herzegovina, Serbia, Norway, Latvia, Finland, Lithuania, Czech Republic, Germany, Slovakia, Greece
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics of Darexaban and MetabolitesFrance
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacodynamic and Pharmacokinetic InteractionFrance